Inventor
LEMIEUX RENE MARC
US12 patents
⚠️ This page may combine multiple inventors who share the name “LEMIEUX RENE MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
7 patentsUS6844360B2Jan 18, 2005
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
BOEHRINGER INGELHEIM PHARMA24 citations92
US7601714B2Oct 13, 2009
Pyrimidine derivatives useful as inhibitors of PKC-theta
BOEHRINGER INGELHEIM PHARMA33 citations91
US6852748B1Feb 8, 2005
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
BOEHRINGER INGELHEIM PHARMA24 citations91
US7589115B2Sep 15, 2009
Derivatives of [6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-sulfonylamino]-propionamide
BOEHRINGER INGELHEIM PHARMA4 citations73
US7345074B2Mar 18, 2008
Derivatives of [6,7-dihydro-5H-imidazol[1,2-a]imidazole-3-sulfonylamino]-propionamide
BOEHRINGER INGELHEIM PHARMA8 citations73
US7304067B2Dec 4, 2007
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
BOEHRINGER INGELHEIM PHARMA8 citations73
US7462637B2Dec 9, 2008
Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
BOEHRINGER INGELHEIM PHARMA6 citations72
BOEHRINGER INGELHEIM INT
3 patentsUS7572921B2Aug 11, 2009
Substituted benzylimidazoles useful for the treatment of inflammatory diseases
BOEHRINGER INGELHEIM INT4 citations62
US7468382B2Dec 23, 2008
Pyridine derivatives useful as inhibitors of PKC-theta
BOEHRINGER INGELHEIM INT3 citations61
US7517897B2Apr 14, 2009
Derivatives of 6,7-dihydro-5h -imidazo[1,2-a] imidazole-3-sulfonic acid
BOEHRINGER INGELHEIM INT5 citations58